Trials / Sponsors / Central European Society for Anticancer Drug Research
Central European Society for Anticancer Drug Research
Academic / Other · 7 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Study in Patients With SCLC of Veliparib in Combination With Topotecan Small Cell Lung Cancer SCLC | Phase 1 | 2016-10-01 |
| Completed | Sequential Therapy in Metastatic Renal Cell Carinoma Metastatic Renal Cell Carcinoma | Phase 2 | 2012-10-01 |
| Completed | Central European Society for Anticancer Research (CESAR) Study of Paclitaxel Therapeutic Drug Monitoring Carcinoma, Non-Small-Cell Lung | Phase 3 | 2011-03-01 |
| Completed | CESAR Study in Prostate Cancer With Temsirolimus Added to Standard Docetaxel Therapy (CEPTAS) Prostatic Neoplasms | Phase 1 / Phase 2 | 2010-07-01 |
| Completed | Study in Non-Clear Cell Renal Carcinoma (Ncc-RCC) Temsirolimus Versus Sunitinib Non-clear Cell Renal Cell Cancer | Phase 2 | 2009-07-01 |
| Completed | FOLFIRI and Sunitinib in Metastatic Colorectal Cancer Metastatic Colorectal Cancer, Liver Metastases | Phase 2 | 2008-08-01 |
| Completed | First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced or Metastatic Pancreatic Cancer Pancreatic Cancer | Phase 2 | 2008-04-01 |